Interferon α may be back on track to treat acute myeloid leukemia

Evelien L J M Smits1, Sébastien Anguille, Zwi N Berneman

  • 1Tumor Immunology Group, Laboratory of Experimental Hematology, Vaccine and Infectious Disease Institute, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium ; Center for Cell Therapy and Regenerative Medicine, Antwerp University Hospital, Antwerp, Belgium.

Oncoimmunology
|June 5, 2013
PubMed